Serum Bilirubin Level Changes in Multiple Sclerosis Patients

Authors

  • Akbari, Roya Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Ashtar, Fereshte Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Barzegar, Mahdi Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Dehghani, Leila Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Esmaeil, Nafiseh Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Mirmosayyeb, Omid Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Mohammadi, Abdolrasoul Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Shaygannejad, Vahid Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Valipour, Samane Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Vesal, Sahar Neurosciences Research Center, Alzahra Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract:

Background: Multiple Sclerosis (MS) is a demyelinating disorder of the Central Nervous System (CNS). In addition to the role of immune mediated mechanisms, oxidative and nitrosative stress also play an important role in neuropathology of MS. Bilirubin as an endogenous antioxidant has neuroprotective effects; however few studies have assessed the association between serum bilirubin level and MS. Objectives: To evaluate serum level of bilirubin in MS patients. Materials and Methods: Serum samples were collected from participants who referred to Kashani MS clinic in Isfahan between July 2016 and July 2017. A total of 80 MS patients (67 females and 13 males) and 94 Healthy Control subjects (HCs) (62 female and 32 male) enrolled. Compression of bilirubin levels between MS patients and HCs was done with covariance analysis. Regression analysis was used to assess the relation between bilirubin concentration and EDSS. SPSS software version 17.0 for Windows (SPSS, Chicago, IL, USA) was used. Results: The level of Direct bilirubin (Dbil) was significantly lower in MS patients compared with HCs (P=0.02). Otherwise the serum concentration of Total bilirubin (Tbil) and in Direct bilirubin (Ibil) were higher in MS patients, but it was not statistically significant. There was a negative correlation between Extended Disability Status Scale (EDSS) and bilirubin levels (Tbil, Dbil and Ibil) but it was not significant.  Conclusion: Bilirubin level is lower in MS patients and deficit of its antioxidant level may play role in neuropathology of MS.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

serum prolactin level in multiple sclerosis patients

background: multiple sclerosis (ms) is the most common demyelinating disease. an autoimmune basis has been confirmed for pathogenesis of ms. prolactin (prl) has roles in these mechanisms. its serum levels change in ms according to some reports. the purpose of this study was to survey these changes in ms patients. methods: sixty ms patients were included in this cross-sectional study. the same n...

full text

Psychological Changes in Patients With Multiple Sclerosis

Introduction: Multiple Sclerosis (MS) as a stressful event, despite causing negative psychological changes, may lead to positive ones as well. Objective: This study was mainly conducted to examine the implications of posttraumatic growth and demoralization and also to determine the relationship between them in patients with MS. Materials and Methods: This was a cross-sectional study, in which...

full text

The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica

Introduction: Midkine (MK), a heparin-binding growth factor, is involved in neurological diseases by mediating the inflammatory responses through enhancing the leukocyte migration. The present study assesses the serum concentration of this growth factor among newly developed Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) patients. Methods: The present research, as a cross-sectional stu...

full text

Serum Metabolic Profile in Multiple Sclerosis Patients

Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterati...

full text

Correlation of Midkine Serum Level with Pro- and Anti-Inflamatory Cytokines in Multiple Sclerosis

Background: Midkine (MK) is a heparin-binding growth factor with promoting effects in inflammatory responses through enhancing leukocytes migration. Objective: To study the correlation between MK serum levels and concentration of inflammatory cytokines in Multiple Sclerosis (MS) patients. Methods: We evaluated the MK level and its relationship with inflammatory cytokines (IL-17 and IL-23) and a...

full text

The Serum Amyloid β Level in Multiple Sclerosis: A Case- Control Study

Background: Multiple sclerosis (MS) is one of the most common autoimmune diseases in adults that cause disability in patients. Different studies were conducted on more rapid diagnosis of the disease such as measuring serum or cerebrospinal fluid (CSF) contents. Objectives: The current study aimed at measuring amyloid β (Aβ) serum levels in patients with relapsing-remitting MS. Mater...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue 12

pages  30- 34

publication date 2018-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023